321 related articles for article (PubMed ID: 24244607)
21. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of NKX6.1 is closely associated with progressive features and predicts unfavorable prognosis in human primary hepatocellular carcinoma.
Huang LL; Zhang Y; Zhang JX; He LJ; Lai YR; Liao YJ; Tian XP; Deng HX; Liang YJ; Kung HF; Xie D; Zhu SL
Tumour Biol; 2015 Jun; 36(6):4405-15. PubMed ID: 25596704
[TBL] [Abstract][Full Text] [Related]
23. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.
Liu M; Yan Q; Sun Y; Nam Y; Hu L; Loong JH; Ouyang Q; Zhang Y; Li HL; Kong FE; Li L; Li Y; Li MM; Cheng W; Jiang LX; Fang S; Yang XD; Mo JQ; Gong YF; Tang YQ; Li Y; Yuan YF; Ma NF; Lin G; Ma S; Wang JG; Guan XY
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):6103-6113. PubMed ID: 32123069
[TBL] [Abstract][Full Text] [Related]
24. High expression of neuro-oncological ventral antigen 1 correlates with poor prognosis in hepatocellular carcinoma.
Zhang YA; Zhu JM; Yin J; Tang WQ; Guo YM; Shen XZ; Liu TT
PLoS One; 2014; 9(3):e90955. PubMed ID: 24608171
[TBL] [Abstract][Full Text] [Related]
25. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
26. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.
Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236
[TBL] [Abstract][Full Text] [Related]
27. Association of mortalin (HSPA9) with liver cancer metastasis and prediction for early tumor recurrence.
Yi X; Luk JM; Lee NP; Peng J; Leng X; Guan XY; Lau GK; Beretta L; Fan ST
Mol Cell Proteomics; 2008 Feb; 7(2):315-25. PubMed ID: 17934217
[TBL] [Abstract][Full Text] [Related]
28. Expression of intercellular adhesion molecule 1 by hepatocellular carcinoma stem cells and circulating tumor cells.
Liu S; Li N; Yu X; Xiao X; Cheng K; Hu J; Wang J; Zhang D; Cheng S; Liu S
Gastroenterology; 2013 May; 144(5):1031-1041.e10. PubMed ID: 23376424
[TBL] [Abstract][Full Text] [Related]
29. Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy.
Liu J; Liu JF; Wang K; Yan ZL; Wan XY; Huang AM; Wang YZ; Li J; Xia Y; Shi LH; Jiao BH; Zhang Y; Shen F
Oncol Rep; 2015 Dec; 34(6):3174-86. PubMed ID: 26398566
[TBL] [Abstract][Full Text] [Related]
30. MiR-214 targets β-catenin pathway to suppress invasion, stem-like traits and recurrence of human hepatocellular carcinoma.
Xia H; Ooi LL; Hui KM
PLoS One; 2012; 7(9):e44206. PubMed ID: 22962603
[TBL] [Abstract][Full Text] [Related]
31. Increased expression of OCT4 is associated with low differentiation and tumor recurrence in human hepatocellular carcinoma.
Dong Z; Zeng Q; Luo H; Zou J; Cao C; Liang J; Wu D; Liu L
Pathol Res Pract; 2012 Sep; 208(9):527-33. PubMed ID: 22824146
[TBL] [Abstract][Full Text] [Related]
32. HOXB7 accelerates the malignant progression of hepatocellular carcinoma by promoting stemness and epithelial-mesenchymal transition.
Huan HB; Yang DP; Wen XD; Chen XJ; Zhang L; Wu LL; Bie P; Xia F
J Exp Clin Cancer Res; 2017 Jun; 36(1):86. PubMed ID: 28646927
[TBL] [Abstract][Full Text] [Related]
33. Inflammation Promotes Expression of Stemness-Related Properties in HBV-Related Hepatocellular Carcinoma.
Chang TS; Chen CL; Wu YC; Liu JJ; Kuo YC; Lee KF; Lin SY; Lin SE; Tung SY; Kuo LM; Tsai YH; Huang YH
PLoS One; 2016; 11(2):e0149897. PubMed ID: 26919045
[TBL] [Abstract][Full Text] [Related]
34. High expression of patched homolog-1 messenger RNA and glioma-associated oncogene-1 messenger RNA of sonic hedgehog signaling pathway indicates a risk of postresection recurrence of hepatocellular carcinoma.
Jeng KS; Sheen IS; Jeng WJ; Lin CC; Lin CK; Su JC; Yu MC; Fang HY
Ann Surg Oncol; 2013 Feb; 20(2):464-73. PubMed ID: 22911366
[TBL] [Abstract][Full Text] [Related]
35. Circulating tumor and cancer stem cells in hepatitis C virus-associated liver disease.
Bahnassy AA; Zekri AR; El-Bastawisy A; Fawzy A; Shetta M; Hussein N; Omran D; Ahmed AA; El-Labbody SS
World J Gastroenterol; 2014 Dec; 20(48):18240-8. PubMed ID: 25561791
[TBL] [Abstract][Full Text] [Related]
36. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of PRRX1 Confers Cancer Stem Cell-Like Properties and Predicts Poor Prognosis in Hepatocellular Carcinoma.
Hirata H; Sugimachi K; Takahashi Y; Ueda M; Sakimura S; Uchi R; Kurashige J; Takano Y; Nanbara S; Komatsu H; Saito T; Shinden Y; Iguchi T; Eguchi H; Atsumi K; Sakamoto K; Doi T; Hirakawa M; Honda H; Mimori K
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1402-9. PubMed ID: 25404478
[TBL] [Abstract][Full Text] [Related]
38. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
39. Cell fate determination factor Dachshund reprograms breast cancer stem cell function.
Wu K; Jiao X; Li Z; Katiyar S; Casimiro MC; Yang W; Zhang Q; Willmarth NE; Chepelev I; Crosariol M; Wei Z; Hu J; Zhao K; Pestell RG
J Biol Chem; 2011 Jan; 286(3):2132-42. PubMed ID: 20937839
[TBL] [Abstract][Full Text] [Related]
40. Low CADM2 expression predicts high recurrence risk of hepatocellular carcinoma patients after hepatectomy.
Yang S; Yan HL; Tao QF; Yuan SX; Tang GN; Yang Y; Wang LL; Zhang YL; Sun SH; Zhou WP
J Cancer Res Clin Oncol; 2014 Jan; 140(1):109-16. PubMed ID: 24240726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
